F. Zaidi

发表

Immunogenicity of a DNA vaccine candidate for COVID-19

J. Kim, D. Weiner, Jian Yan, 2020, Nature Communications.

Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine - Preliminary Report.

S. Trottier, D. Weiner, G. Kobinger, 2017, The New England journal of medicine.

Intradermal delivery of a synthetic DNA vaccine protects macaques from Middle East respiratory syndrome coronavirus

D. Weiner, H. Feldmann, Ami Patel, 2021, JCI insight.

Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial

D. Weiner, G. Kobinger, M. Robb, 2019, The Lancet Infectious Diseases.

Rapid development of a synthetic DNA vaccine for COVID-19

Daniel W. Kulp, J. Kim, D. Weiner, 2020 .

Induction of tier-2 neutralizing antibodies in mice with a DNA-encoded HIV envelope native like trimer

Daniel W. Kulp, D. Weiner, J. Pallesen, 2022, Nature communications.

Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates

D. Weiner, I. Maričić, Ami Patel, 2021, bioRxiv.

Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: a preliminary report of a randomized, blinded, placebo-controlled, Phase 2 clinical trial in adults at high risk of viral exposure

J. Kim, J. Shea, P. Tebas, 2021, medRxiv.

Immunogenicity of a DNA vaccine candidate for COVID-19

Daniel W. Kulp, J. Kim, D. Weiner, 2020, Nature Communications.

Neutralization of hepatitis B virus by a novel DNA-encoded monoclonal antibody

D. Weiner, S. Kudchodkar, K. Ugen, 2020, Human vaccines & immunotherapeutics.

Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine.

S. Trottier, D. Weiner, G. Kobinger, 2021, The New England journal of medicine.

Intradermal-delivered DNA vaccine induces durable immunity mediating a reduction in viral load in a rhesus macaque SARS-CoV-2 challenge model

Daniel W. Kulp, J. Kim, D. Weiner, 2021, Cell Reports Medicine.

Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial

D. Weiner, I. Maričić, J. Shea, 2020, EClinicalMedicine.

Novel prostate cancer immunotherapy with a DNA-encoded anti-prostate-specific membrane antigen monoclonal antibody

N. Sardesai, D. Weiner, S. Kudchodkar, 2017, Cancer Immunology, Immunotherapy.

Intradermal-delivered DNA vaccine provides anamnestic protection in a rhesus macaque SARS-CoV-2 challenge model

Daniel W. Kulp, J. Kim, D. Weiner, 2020, bioRxiv.

Induction of tier-2 neutralizing antibodies in mice with a DNA-encoded HIV envelope native like trimer

Daniel W. Kulp, D. Weiner, J. Pallesen, 2022, Nature Communications.

SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial

J. Kim, J. Shea, P. Tebas, 2021, medRxiv.

Identification of Novel Neutralizing Monoclonal Antibodies against SARS-CoV-2 Spike Glycoprotein

Daniel W. Kulp, D. Weiner, K. Ugen, 2021, ACS Pharmacology & Translational Science.

Techniques for Developing and Assessing Immune Responses Induced by Synthetic DNA Vaccines for Emerging Infectious Diseases.

S. Kudchodkar, J. Maslow, M. Jeong, 2021, Methods in molecular biology.

Synthetic DNA Vaccines Adjuvanted with pIL-33 Drive Liver-Localized T Cells and Provide Protection from Plasmodium Challenge in a Mouse Model

D. Weiner, A. Aly, Sophia M. Reeder, 2020, Vaccines.

Novel prostate cancer immunotherapy with a DNA-encoded anti-prostate-specific membrane antigen monoclonal antibody

N. Sardesai, D. Weiner, S. Kudchodkar, 2017, Cancer Immunology, Immunotherapy.